Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979249 · ClinicalTrials.gov registry record · NA
Oral Iron for Erythropoietic Protoporphyrias
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02979249 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 16 participants.
The verdict
NCT02979249, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.
Interventions
- DRUG Oral Iron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02979249
The ClinicalTrials.gov registry entry for NCT02979249 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Iron is the first listed.
NCT02979249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02979249 about?
NCT02979249 is a clinical study titled "Oral Iron for Erythropoietic Protoporphyrias". In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to dete...
What is the current status of trial NCT02979249?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-12. Estimated completion is 2019-07-19.
What interventions are being tested in trial NCT02979249?
The interventions under investigation include: Oral Iron (DRUG).
Who is sponsoring clinical trial NCT02979249?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.